Literature DB >> 10223929

Sequence analysis of the gyrA and parC homologues of a wild-type strain of Vibrio parahaemolyticus and its fluoroquinolone-resistant mutants.

J Okuda1, E Hayakawa, M Nishibuchi, T Nishino.   

Abstract

Vibrio parahaemolyticus causes seafood-borne gastroenteritis in humans. It is particularly important in Japan, where raw seafood is frequently consumed. Fluoroquinolone is one of the current drugs of choice for treating patients infected by V. parahaemolyticus because resistant strains are rarely found. To study a possible fluoroquinolone resistance mechanism in this organism, nucleotide sequences that are homologous to known gyrA and parC genes have been cloned from V. parahaemolyticus AQ3815 and sequenced by amplification with degenerate primers of the quinolone resistance-determining region (QRDR), followed by cassette ligation-mediated PCR. Open reading frames encoding polypeptides of 878 and 761 amino acid residues were detected in the gyrA and parC homologues, respectively. The V. parahaemolyticus GyrA and ParC sequences were most closely related to Erwinia carotovora GyrA (76% identity) and Escherichia coli ParC (69% identity) sequences, respectively. Ciprofloxacin-resistant mutants of AQ3815 were obtained on an agar medium by multistep selection with increasing levels of the quinolone. One point mutation only in the gyrA QRDR was detected among mutants with low- to intermediate-level resistance, while point mutations in both the gyrA and parC QRDRs were detected only in strains with high-level resistance. These results strongly suggest that, as in other gram-negative bacteria, GyrA and ParC are the primary and secondary targets, respectively, of ciprofloxacin in V. parahaemolyticus.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10223929      PMCID: PMC89126     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  45 in total

Review 1.  Linkage map of Escherichia coli K-12, edition 8.

Authors:  B J Bachmann
Journal:  Microbiol Rev       Date:  1990-06

2.  Cloning and sequence analysis of gyrA gene of Klebsiella pneumoniae.

Authors:  G P Dimri; H K Das
Journal:  Nucleic Acids Res       Date:  1990-01-11       Impact factor: 16.971

3.  [Drug-resistance and transferable R plasmids in Vibrio cholerae O-1 and non O-1, V. fluvialis and V. parahaemolyticus recently isolated from human sources].

Authors:  S Matsushita; S Yamada; Y Kudoh; M Ohashi
Journal:  Kansenshogaku Zasshi       Date:  1987-02

4.  Cloning and sequencing of the Escherichia coli gyrA gene coding for the A subunit of DNA gyrase.

Authors:  S L Swanberg; J C Wang
Journal:  J Mol Biol       Date:  1987-10-20       Impact factor: 5.469

Review 5.  DNA topoisomerases.

Authors:  J C Wang
Journal:  Annu Rev Biochem       Date:  1985       Impact factor: 23.643

6.  DNA sequence of the E. coli gyrB gene: application of a new sequencing strategy.

Authors:  T Adachi; M Mizuuchi; E A Robinson; E Appella; M H O'Dea; M Gellert; K Mizuuchi
Journal:  Nucleic Acids Res       Date:  1987-01-26       Impact factor: 16.971

Review 7.  Cholera and other vibrioses in the United States.

Authors:  J G Morris; R E Black
Journal:  N Engl J Med       Date:  1985-02-07       Impact factor: 91.245

8.  Nalidixic acid-resistant mutations of the gyrB gene of Escherichia coli.

Authors:  J Yamagishi; H Yoshida; M Yamayoshi; S Nakamura
Journal:  Mol Gen Genet       Date:  1986-09

Review 9.  Current perspectives on the epidemiology and pathogenesis of clinically significant Vibrio spp.

Authors:  J M Janda; C Powers; R G Bryant; S L Abbott
Journal:  Clin Microbiol Rev       Date:  1988-07       Impact factor: 26.132

10.  DNA cloning and organization of the Staphylococcus aureus gyrA and gyrB genes: close homology among gyrase proteins and implications for 4-quinolone action and resistance.

Authors:  R Hopewell; M Oram; R Briesewitz; L M Fisher
Journal:  J Bacteriol       Date:  1990-06       Impact factor: 3.490

View more
  5 in total

1.  gyrA mutations associated with quinolone resistance in Bacteroides fragilis group strains.

Authors:  H Oh; N El Amin; T Davies; P C Appelbaum; C Edlund
Journal:  Antimicrob Agents Chemother       Date:  2001-07       Impact factor: 5.191

2.  Type II topoisomerase quinolone resistance-determining regions of Aeromonas caviae, A. hydrophila, and A. sobria complexes and mutations associated with quinolone resistance.

Authors:  Marisol Goñi-Urriza; Corinne Arpin; Michèle Capdepuy; Véronique Dubois; Pierre Caumette; Claudine Quentin
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

3.  Spontaneous quinolone resistance in the zoonotic serovar of Vibrio vulnificus.

Authors:  Francisco J Roig; A Llorens; B Fouz; C Amaro
Journal:  Appl Environ Microbiol       Date:  2009-02-13       Impact factor: 4.792

4.  Vibrio alginolyticus Survives From Ofloxacin Stress by Metabolic Adjustment.

Authors:  Yue Yin; Yuanpan Yin; Hao Yang; Zhuanggui Chen; Jun Zheng; Bo Peng
Journal:  Front Microbiol       Date:  2022-03-16       Impact factor: 5.640

5.  Mechanisms of antimicrobial resistance in finfish aquaculture environments.

Authors:  Claudio D Miranda; Alfredo Tello; Patricia L Keen
Journal:  Front Microbiol       Date:  2013-08-22       Impact factor: 5.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.